Stay updated on NC318 Safety and Tolerability in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the NC318 Safety and Tolerability in Solid Tumors Clinical Trial page.

Latest updates to the NC318 Safety and Tolerability in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedAdded a consolidated Locations section listing study sites in California, Connecticut, New Jersey, New York, Pennsylvania, and Texas, and removed the separate state Location subsections. Updated the page revision to v3.3.3.SummaryDifference0.7%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new revision entry (v3.3.2) was added and the previous revision (v3.3.1) removed, reflecting a minor version update that does not modify study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check30 days agoChange DetectedMinor page revision updated from v3.2.0 to v3.3.1; no study content, eligibility criteria, or contact information were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedRemoved the site-wide funding/operating-status notice from the page.SummaryDifference0.3%

- Check45 days agoChange DetectedNo significant changes were observed; the page content and structure appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedResults data has been posted for NC318; a Results tab is now available. The reported outcomes include safety measures (TEAEs) and efficacy endpoints (ORR, DoR, DCR, PFS, OS) plus PK/PD data.SummaryDifference0.5%

Stay in the know with updates to NC318 Safety and Tolerability in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NC318 Safety and Tolerability in Solid Tumors Clinical Trial page.